Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. We provide sustainable access to innovative therapies in the areas of haematology, immunology, and specialty indications. Today, we employ approximately 1,800 people across Europe, North America, the Middle East and Asia. In 2023, our revenue amounted to SEK 22.1 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at sobi.com.
View Top Employees from Sobi - Swedish Orphan Biovitrum AB (publ)| Website | http://www.sobi.com |
| Ticker | SOBI |
| Revenue | $1.5 billion |
| Funding | $152.5 million |
| Employees | 1,896 (1,146 on RocketReach) |
| Founded | 2009 |
| Address | 23a Tomtebodavägen, Stockholm 112 76, SE |
| Phone | (468) 697-2000 |
| Fax | (468) 697-2330 |
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Orphan Drugs, Healthcare, Hereditary Metabolic Disorders, Hematological Diseases, Therapeutic Oncology, Autoimmune Diseases, Haemophilia |
| Keywords | Immunology, Innovative Medical Devices, Orphan Drug Development |
| Competitors | 3SBio Inc., Amneal Pharmaceuticals, Dr Reddy's NZ Ltd, Endo International plc, Recordati |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Sobi - Swedish Orphan Biovitrum AB (publ) employee's phone or email?
Sobi - Swedish Orphan Biovitrum AB (publ) Questions
The Sobi - Swedish Orphan Biovitrum AB (publ) annual revenue was $1.5 billion in 2024.
1,146 people are employed at Sobi - Swedish Orphan Biovitrum AB (publ).
The NAICS codes for Sobi - Swedish Orphan Biovitrum AB (publ) are [325, 32541, 32, 3254].
The SIC codes for Sobi - Swedish Orphan Biovitrum AB (publ) are [283, 28].
Top Sobi - Swedish Orphan Biovitrum AB (publ) Employees
Related Companies
